This Request is the fourth Refresh for Contracts HCNS119914 and CUAPHA2016. The purpose of this Refresh is to seek Offers for Deferasirox, which has recently become an off-patent drug, resulting in material changes in the market environment since the current contract commenced in December 2016. Contract HCNS119914 for the supply of Pharmaceutical Products to Western Australian Public Health Care Units (WAPHCUs) was awarded in December 2016 to meet the requirements of the WA health system. To meet the pharmaceutical requirements of users outside of the WA health system, the Department of Finance has also established a Common Use Arrangement (CUA) (CUAPHA2016) under the same terms and conditions as HCNS119914. This enables other appropriately licensed Government agencies and Approved CUA Users to purchase pharmaceutical products under a contractual framework. It is the intention of the Department of Finance and Health Support Services to conclude CUAPHA2016 on 30 June 2022. Concurrently, HCNS119914 will be varied to allow access for approved users outside of the WA health system. The Department of Finance and Health Support Services will communicate with both Contractors and Customers throughout this process.
Public award record
Pharmaceutical Products (Refresh D) - Single Molecule: Deferasirox
- Location
- Gascoyne Goldfields/Esperance Great Southern Kimberley Mid West Peel Perth Metropolitan Pilbara South West Wheatbelt
- Public buyer
- Health Support Services
AWARD DETAILS
- Buyer
- Health Support Services
- State
- WA
- Published
- Contract start
- —
- Category
- Hematolic drugs - (100%)
- Value
- $139.7k
- Value type
- (Estimate)
- Procurement method
- Open Advertisement
- Record updated